31 Healthcare Stocks Moving In Friday's Pre-Market Session

Gainers

• Flexion Therapeutics, Inc. FLXN stock surged 24.6% to $23.90 during Friday's pre-market session. The market value of their outstanding shares is at $655.0 million. The most recent rating by Raymond James, on December 27, is at Strong Buy, with a price target of $28.00.
• Rite Aid, Inc. RAD stock moved upwards by 15.1% to $22.10. The market value of their outstanding shares is at $497.1 million.
• Verona Pharma, Inc. VRNA stock increased by 14.7% to $7.55. The market cap stands at $61.8 million.
• Genfit, Inc. GNFT shares moved upwards by 11.1% to $21.07. The market cap seems to be at $560.7 million.
• Assertio Therapeutics, Inc. ASRT shares moved upwards by 9.6% to $1.48. The market cap seems to be at $61.3 million.
• Onconova Therapeutics, Inc. ONTX stock rose 8.4% to $0.34. The market cap seems to be at $4.3 million.
• Mereo BioPharma Group, Inc. MREO shares increased by 7.0% to $2.30. The market value of their outstanding shares is at $54.9 million.
• Cassava Sciences, Inc. SAVA stock rose 6.7% to $4.30. The market cap seems to be at $20.6 million.
• DBV Technologies, Inc. DBVT stock increased by 6.4% to $11.11. The market value of their outstanding shares is at $676.0 million. The most recent rating by Citigroup, on December 16, is at Buy, with a price target of $14.00.
• Microbot Medical, Inc. MBOT shares surged 6.0% to $14.84. The market cap seems to be at $21.2 million. The most recent rating by H.C. Wainwright, on December 24, is at Buy, with a price target of $12.00.
• Bionano Genomics, Inc. BNGO shares surged 3.9% to $1.08. The market value of their outstanding shares is at $20.9 million.
• Advaxis, Inc. ADXS stock increased by 3.6% to $0.72. The market cap seems to be at $25.8 million.
• Spectrum Pharmaceuticals, Inc. SPPI shares rose 3.4% to $3.62. The market value of their outstanding shares is at $1.0 billion. The most recent rating by Cantor Fitzgerald, on December 26, is at Neutral, with a price target of $4.00.
• TG Therapeutics, Inc. TGTX shares increased by 3.4% to $11.51. The market value of their outstanding shares is at $659.9 million. The most recent rating by Cantor Fitzgerald, on November 14, is at Overweight, with a price target of $19.00.
• PAVmed, Inc. PAVM stock increased by 3.4% to $1.22. The market cap stands at $33.1 million.
• Spring Bank, Inc. SBPH shares moved upwards by 3.3% to $1.24. The market cap seems to be at $48.8 million. The most recent rating by PiperJaffray, on December 27, is at Neutral, with a price target of $1.70.
• Guardion Health Sciences, Inc. GHSI stock rose 3.2% to $0.21. The market cap stands at $20.3 million.
• Oncolytics Biotech, Inc. ONCY shares surged 2.8% to $2.90. The market cap stands at $30.6 million.
• Citius Pharmaceuticals, Inc. CTXR shares moved upwards by 2.6% to $1.18. The market cap seems to be at $13.2 million.
• Qiagen, Inc. QGEN shares rose 2.4% to $33.71. The market cap stands at $9.6 billion. The most recent rating by Bank of America, on December 26, is at Underperform, with a price target of $28.00.
• NewLink Genetics, Inc. NLNK shares increased by 2.2% to $3.20. The market value of their outstanding shares is at $56.7 million.
• Outlook Therapeutics, Inc. OTLK stock surged 2.0% to $0.56. The market cap seems to be at $29.7 million.
• AstraZeneca, Inc. AZN shares increased by 1.8% to $50.77. The market value of their outstanding shares is at $126.9 billion. The most recent rating by Cowen & Co., on December 02, is at Outperform, with a price target of $55.00.
• GlaxoSmithKline, Inc. GSK shares increased by 1.8% to $47.76. The market value of their outstanding shares is at $112.9 billion. According to the most recent rating by UBS, on November 21, the current rating is at Buy.
• Smith & Nephew, Inc. SNN stock increased by 1.3% to $48.66. The market cap stands at $19.5 billion. According to the most recent rating by Bernstein, on November 12, the current rating is at Outperform.

Losers

• Acasti Pharma, Inc. ACST shares plummeted 5.2% to $2.55 during Friday's pre-market session. The market cap stands at $158.4 million. The most recent rating by B. Riley FBR, on November 18, is at Buy, with a price target of $8.00.
• Helius Medical Tech, Inc. HSDT stock plummeted 4.8% to $1.00. The market value of their outstanding shares is at $15.6 million.
• Acorda Therapeutics, Inc. ACOR shares declined 4.7% to $2.62. The market value of their outstanding shares is at $76.8 million. According to the most recent rating by JP Morgan, on October 24, the current rating is at Underweight.
• Liquidia Technologies, Inc. LQDA stock fell 3.0% to $4.90. The market cap stands at $81.7 million. The most recent rating by Wedbush, on December 26, is at Outperform, with a price target of $37.00.
• Diffusion Pharmaceuticals, Inc. DFFN stock declined 1.8% to $0.40. The market value of their outstanding shares is at $3.9 million. The most recent rating by H.C. Wainwright, on December 18, is at Buy, with a price target of $3.50.
• Aurora Cannabis, Inc. ACB shares plummeted 1.5% to $1.98. The market value of their outstanding shares is at $2.6 billion. The most recent rating by Piper Jaffray, on October 22, is at Neutral, with a price target of $4.00.